CVE-2023-37613: Assemblysoftware Trialworks

Medium severity, CVSS 6.1. EPSS: 0.4% chance of exploitation in the next 30 days.

A cross-site scripting (XSS) vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter.

Affected products

Published 2023-07-24. Last modified 2026-06-17.